Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 38,660 shares at $41.29 ($1.6M) on 2018-12-06, disclosed to the SEC on 2018-12-06.
Scheduled sale ($1.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.93 | 2,287 | $100K | 6.3% |
| 2 | $40.75 | 18,937 | $772K | 48.6% |
| 3 | $40.91 | 1,836 | $75K | 4.7% |
| 4 | $40.93 | 6,373 | $261K | 16.4% |
| 5 | $41.29 | 9,227 | $381K | 24.0% |
| Total | $41.10 avg | 38,660 |
| $1.6M |
| 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |